Association between HLA class I and class II alleles and the outcome of West Nile virus infection: an exploratory study. 2011

Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
Blood Systems Research Institute, San Francisco, California, United States of America. mlanteri@bloodsystems.org

BACKGROUND West Nile virus (WNV) infection is asymptomatic in most individuals, with a minority developing symptoms ranging from WNV fever to serious neuroinvasive disease. This study investigated the impact of host HLA on the outcome of WNV disease. METHODS A cohort of 210 non-Hispanic mostly white WNV(+) subjects from Canada and the U.S. were typed for HLA-A, B, C, DP, DQ, and DR. The study subjects were divided into three WNV infection outcome groups: asymptomatic (AS), symptomatic (S), and neuroinvasive disease (ND). Allele frequency distribution was compared pair-wise between the AS, S, and ND groups using χ2 and Fisher's exact tests and P values were corrected for multiple comparisons (Pc). Allele frequencies were compared between the groups and the North American population (NA) used as a control group. Logistic regression analysis was used to evaluate the potential synergistic effect of age and HLA allele phenotype on disease outcome. RESULTS The alleles HLA-A*68, C*08 and DQB*05 were more frequently associated with severe outcomes (ND vs. AS, P(A*68) = 0.013/Pc = 0.26, P(C*08) = 0.0075/Pc = 0.064, and P(DQB1*05) = 0.029/Pc = 0.68), However the apparent DQB1*05 association was driven by age. The alleles HLA-B*40 and C*03 were more frequently associated with asymptomatic outcome (AS vs. S, P(B*40) = 0.021/Pc = 0.58 and AS vs. ND P(C*03) = 0.039/Pc = 0.64) and their frequencies were lower within WNV(+) subjects with neuroinvasive disease than within the North American population (NA vs. S, P(B*40) = 0.029 and NA vs. ND, P(C*03) = 0.032). CONCLUSIONS Host HLA may be associated with the outcome of WNV disease; HLA-A*68 and C*08 might function as "susceptible" alleles, whereas HLA-B*40 and C*03 might function as "protective" alleles.

UI MeSH Term Description Entries
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D000949 Histocompatibility Antigens Class II Large, transmembrane, non-covalently linked glycoproteins (alpha and beta). Both chains can be polymorphic although there is more structural variation in the beta chains. The class II antigens in humans are called HLA-D ANTIGENS and are coded by a gene on chromosome 6. In mice, two genes named IA and IE on chromosome 17 code for the H-2 antigens. The antigens are found on B-lymphocytes, macrophages, epidermal cells, and sperm and are thought to mediate the competence of and cellular cooperation in the immune response. The term IA antigens used to refer only to the proteins encoded by the IA genes in the mouse, but is now used as a generic term for any class II histocompatibility antigen. Antigens, Immune Response,Class II Antigens,Class II Histocompatibility Antigen,Class II Major Histocompatibility Antigen,Ia Antigens,Ia-Like Antigen,Ia-Like Antigens,Immune Response Antigens,Immune-Associated Antigens,Immune-Response-Associated Antigens,MHC Class II Molecule,MHC II Peptide,Class II Antigen,Class II Histocompatibility Antigens,Class II MHC Proteins,Class II Major Histocompatibility Antigens,Class II Major Histocompatibility Molecules,I-A Antigen,I-A-Antigen,IA Antigen,MHC Class II Molecules,MHC II Peptides,MHC-II Molecules,Antigen, Class II,Antigen, I-A,Antigen, IA,Antigen, Ia-Like,Antigens, Class II,Antigens, Ia,Antigens, Ia-Like,Antigens, Immune-Associated,Antigens, Immune-Response-Associated,I A Antigen,II Peptide, MHC,Ia Like Antigen,Ia Like Antigens,Immune Associated Antigens,Immune Response Associated Antigens,MHC II Molecules,Molecules, MHC-II,Peptide, MHC II,Peptides, MHC II
D014901 West Nile Fever A mosquito-borne viral illness caused by the WEST NILE VIRUS, a FLAVIVIRUS and endemic to regions of Africa, Asia, and Europe. Common clinical features include HEADACHE; FEVER; maculopapular rash; gastrointestinal symptoms; and lymphadenopathy. MENINGITIS; ENCEPHALITIS; and MYELITIS may also occur. The disease may occasionally be fatal or leave survivors with residual neurologic deficits. (From Joynt, Clinical Neurology, 1996, Ch26, p13; Lancet 1998 Sep 5;352(9130):767-71) Kunjin virus Infection,Encephalitis, West Nile Fever,WNV Infection,West Nile Fever Encephalitis,West Nile Fever Meningitis,West Nile Fever Meningoencephalitis,West Nile Fever Myelitis,West Nile Virus Infection,Infection, Kunjin virus,Infection, WNV,Kunjin virus Infections,WNV Infections
D015331 Cohort Studies Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics. Birth Cohort Studies,Birth Cohort Study,Closed Cohort Studies,Cohort Analysis,Concurrent Studies,Historical Cohort Studies,Incidence Studies,Analysis, Cohort,Cohort Studies, Closed,Cohort Studies, Historical,Studies, Closed Cohort,Studies, Concurrent,Studies, Historical Cohort,Analyses, Cohort,Closed Cohort Study,Cohort Analyses,Cohort Studies, Birth,Cohort Study,Cohort Study, Birth,Cohort Study, Closed,Cohort Study, Historical,Concurrent Study,Historical Cohort Study,Incidence Study,Studies, Birth Cohort,Studies, Cohort,Studies, Incidence,Study, Birth Cohort,Study, Closed Cohort,Study, Cohort,Study, Concurrent,Study, Historical Cohort,Study, Incidence
D015395 Histocompatibility Antigens Class I Membrane glycoproteins consisting of an alpha subunit and a BETA 2-MICROGLOBULIN beta subunit. In humans, highly polymorphic genes on CHROMOSOME 6 encode the alpha subunits of class I antigens and play an important role in determining the serological specificity of the surface antigen. Class I antigens are found on most nucleated cells and are generally detected by their reactivity with alloantisera. These antigens are recognized during GRAFT REJECTION and restrict cell-mediated lysis of virus-infected cells. Class I Antigen,Class I Antigens,Class I Histocompatibility Antigen,Class I MHC Protein,Class I Major Histocompatibility Antigen,MHC Class I Molecule,MHC-I Peptide,Class I Histocompatibility Antigens,Class I Human Antigens,Class I MHC Proteins,Class I Major Histocompatibility Antigens,Class I Major Histocompatibility Molecules,Human Class I Antigens,MHC Class I Molecules,MHC-I Molecules,MHC-I Peptides,Antigen, Class I,Antigens, Class I,I Antigen, Class,MHC I Molecules,MHC I Peptide,MHC I Peptides,Molecules, MHC-I,Peptide, MHC-I,Peptides, MHC-I

Related Publications

Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
October 2018, Immunological investigations,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
March 2014, Iranian journal of medical sciences,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
August 2016, Transfusion,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
September 2011, Scandinavian journal of immunology,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
February 2008, The Journal of infectious diseases,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
November 2002, Human immunology,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
January 2003, Journal of biological regulators and homeostatic agents,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
January 1988, Annals of the New York Academy of Sciences,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
January 2013, PloS one,
Marion C Lanteri, and Zhanna Kaidarova, and Trevor Peterson, and Steven Cate, and Brian Custer, and Shiquan Wu, and Maria Agapova, and Jacqueline P Law, and Thomas Bielawny, and Frank Plummer, and Leslie H Tobler, and Mark Loeb, and Michael P Busch, and Jonathan Bramson, and Ma Luo, and Philip J Norris
June 1998, The Journal of rheumatology,
Copied contents to your clipboard!